ELRIG 2022 POSTER

Developing a patient-derived bladder cancer organoid biobank suitable for large-scale drug screenings

download poster

Case study

Discover how HUB Organoids can accelerate your preclinical drug development to up to 5 years!
> Download now

Fact sheet

Discover how HUB organoids can be applied to your immunotherapy development program
> Download now

White paper

Learn how HUB Organoids can de-risk your drug development pipeline
> Read more

HUB Organoids is now part of the Life Science Business of Merck KGaA, Darmstadt, Germany

FOR RESEARCH USE ONLY. Unless otherwise stated in our catalog or other company documentation
accompanying the product(s), our products are intended for research use only and are not to be used
for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro
diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to
humans or animals.